PharmaCyte Biotech Inc (PMCB)

[Peacefulwendy]

PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agen

SILVER SPRING, Md., July 09, 2015 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that, effective July 10, 2015, American Stock Transfer & Trust Company (“AST”) will replace Signature Stock Transfer as its stock transfer and dividend disbursing agent.

The Chief Executive Officer of PharmaCyte Biotech, Kenneth L. Waggoner, commented on PharmaCyte Biotech’s new stock transfer agent, “We are extremely pleased to announce that we have appointed AST to be our new stock transfer agent. We are confident that our partnership with this fine organization will provide our shareholders with superior customer service and support. In addition, it will enable us to have access to the industry’s leading management resources and will ensure us the highest quality of operational process that we believe will yield tangible financial benefits to PharmaCyte Biotech and its shareholders.”

AST and its affiliates are leading providers of registry services and technology to financial market participants around the globe. With over 40 years of experience, AST is known for providing a superior customer service experience, which is supported by ongoing investments to technology, people and service offerings. AST has premier in-house call centers, innovative software and processing systems that set the industry standard.

AST provides comprehensive stock transfer and employee plan services to over 2,800 public companies and maintains approximately 6,000 issues. AST’s clients are located throughout the United States and in over 22 foreign countries, ranging in size from initial public offerings to Fortune 100 companies. Founded in 1971 and headquartered in New York, AST provides clients around the globe with customized solutions to fit their specific needs along with access to the best systems, services, processes and products available today.

On and after July 10, 2015, all inquiries and correspondence related to stockholder records, transfer of shares, lost certificates, dividend checks or change of address requests should be directed to AST. If you have questions, please call AST at [phone] or email AST at [e-mail]. AST can also be contacted via mail at:

PharmaCyte Biotech Inc.
c/o American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219

On July 10, 2015, welcome letters with detailed information about AST will be mailed directly to all PharmaCyte Biotech registered shareholders with instructions on how to access their account through AST.

http://finance.yahoo.com/news/pharmacyte-biotech-appoints-american-stock-132000177.html